MICA · CARE LEARNING NOTES
Observe, keep care safe and communicate
A symptom arising during infusion must be described and assessed promptly. A drug reaction, anaphylaxis and a local complication are different problems; paramedical observation guides a safe response without independently establishing the diagnosis.
Identify clinical change
Ask what the patient feels and check for itching, rash, flushing, pain, rigors, breathing difficulty, voice change, swelling, faintness or hypotension. Also inspect the infusion site. Airway, breathing or circulatory involvement suggests a severe reaction even without rash. Record the administered product and timing of symptoms.
[1][2]Stop the suspected product and call
Stop the suspected infusion and immediately alert the responsible clinician; activate emergency procedures for severe features. Do not restart merely because symptoms subside. Preserve usable access according to service procedures without delivering residual product. If extravasation is possible, do not flush and apply the product-specific protocol.
[1][2][3]Recognise anaphylaxis and provide support
Begin ABCDE, remain with the patient and request emergency equipment. In anaphylaxis, intramuscular adrenaline is first-line treatment and should be administered promptly by a trained, authorised person following protocol; an antihistamine is not a substitute. Do not allow standing or walking; adapt position to breathing and circulation.
[1]Anaphylaxis may cause respiratory or circulatory compromise without obvious skin signs. Emergency escalation and protocol-based treatment must not wait for a rash. Do not make a patient with a severe reaction walk or suddenly stand; adapt positioning to breathing and circulation.
- Describe respiratory and circulatory signs, not only whether a rash is present.
Prepare handover and prevention
Record product identity, formulation, available batch details, start time, symptoms, observations, cessation and interventions. Keep material required for investigation according to local procedures. Medical review defines monitoring, investigations, pharmacovigilance reporting and future management. Record suspected reactions with their circumstances rather than turning an unassessed hypothesis into a permanently proven allergy.
[1][2]A learning situation
FICTIONAL SITUATION · REFLECTION WITHOUT A SCORE
Fictional situation: during infusion, a patient develops hoarseness, wheeze and faintness. No visible skin wheals are present.
Does the absence of a rash allow observation alone?
Read the reasoning
No. These findings suggest possible anaphylaxis. Stop the suspected product, activate emergency assistance and begin ABCDE. Absence of skin findings must not delay emergency treatment, including intramuscular adrenaline according to protocol and competence. Keep the patient accompanied without standing, and hand over the precise timeline and response to interventions.
References and scope
- Emergency treatment of anaphylaxis: Guidelines for healthcare providers — May 2021 ↗
- The ABCDE Approach ↗
- Clinical procedure — extravasation management of intravenous anti-cancer therapies and contrast media (ID 4156 v.2) ↗
Original documentary teaching summary for adult care. Procedures and medicines depend on professional competence, prescription and institutional procedures. International references do not establish an Algerian protocol. Independent human scientific review remains to be confirmed.